BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22402866)

  • 1. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
    Alves LI; Davini E; Correia MR; Fukui RT; Santos RF; Cunha MR; Rocha DM; Volpini WM; Silva ME
    J Clin Immunol; 2012 Aug; 32(4):778-85. PubMed ID: 22402866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamic acid decarboxylase 65 and islet cell antigen 512/IA-2 autoantibodies in relation to human leukocyte antigen class II DR and DQ alleles and haplotypes in type 1 diabetes mellitus.
    Stayoussef M; Benmansour J; Al-Jenaidi FA; Said HB; Rayana CB; Mahjoub T; Almawi WY
    Clin Vaccine Immunol; 2011 Jun; 18(6):990-3. PubMed ID: 21490167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.
    Wang JP; Zhou ZG; Lin J; Huang G; Zhang C; Yang L; Yuan Y; Zhou HF; Zhou M; Hou C; Zhou WD; Peng H; Hagopian WA
    Tissue Antigens; 2007 Nov; 70(5):369-75. PubMed ID: 17919266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
    Maclaren N; Lan M; Coutant R; Schatz D; Silverstein J; Muir A; Clare-Salzer M; She JX; Malone J; Crockett S; Schwartz S; Quattrin T; DeSilva M; Vander Vegt P; Notkins A; Krischer J
    J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
    Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
    Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
    Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.
    Decochez K; Truyen I; van der Auwera B; Weets I; Vandemeulebroucke E; de Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Pipeleers DG; Gorus FK;
    Diabetologia; 2005 Apr; 48(4):687-94. PubMed ID: 15756536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR, DQ and anti-GAD antibodies in first degree relatives of type I diabetes mellitus.
    Serrano-Ríos M; Gutierrez-López MD; Pérez-Bravo F; Martínez MT; Antona J; Rowley M; Mackay I; Zimmet P
    Diabetes Res Clin Pract; 1996 Oct; 34 Suppl():S133-9. PubMed ID: 9015682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
    Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
    Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
    Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
    Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among 64k autoantibodies, pancreatic beta-cell function, HLA-DR antigens and HLA-DQ genes in patients with insulin-dependent diabetes mellitus in Korea.
    Lee HC; Cha BS; Nam MS; Song YD; Lim SK; Kim DH; Huh KB; Koh Y
    Korean J Intern Med; 1995 Jan; 10(1):1-9. PubMed ID: 7626550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
    Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
    Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
    J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group.
    Kimpimäki T; Kulmala P; Savola K; Vähäsalo P; Reijonen H; Ilonen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1126-32. PubMed ID: 10720050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of protein tyrosine phosphatase non-receptor type 22 gene functional variant C1858T, HLA-DQ/DR genotypes and autoantibodies with susceptibility to type-1 diabetes mellitus in Kuwaiti Arabs.
    Haider MZ; Rasoul MA; Al-Mahdi M; Al-Kandari H; Dhaunsi GS
    PLoS One; 2018; 13(6):e0198652. PubMed ID: 29924845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings.
    Korhonen S; Knip MM; Kulmala P; Savola K; Akerblom HK; Knip M;
    Diabetes Metab Res Rev; 2002; 18(1):43-8. PubMed ID: 11921417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group.
    Kulmala P; Savola K; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Ilonen J; Tuomilehto J; Akerblom HK; Knip M
    Diabetes; 2000 Jan; 49(1):48-58. PubMed ID: 10615949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.